Literature DB >> 1682937

A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer.

J Milner1.   

Abstract

Cancer is a genetic disease caused by defective control of cell proliferation. As cancer cells divide, the genetic defect is inherited by each daughter cell, leading to tumour development with possible progression to malignancy. The identification of those genes linked with cancer is essential for our understanding of the regulation of cell proliferation and for the therapeutic management of cancer cell growth. Recent studies have revealed that p53 is the most commonly affected gene in human cancer. It is a single copy gene and functions in the regulation of cell proliferation. Mutation of p53 is linked with tumour development, and this may involve abnormal functioning of mutant p53 protein. A mutant allele of p53 is functionally temperature-sensitive and can promote or suppress cell proliferation. The tertiary structure of the mutant protein is also sensitive to temperature and adopts promoter and suppressor forms of p53. A conformation model for the functioning of p53 proposes that wild-type p53 is induced to change from suppressor to promoter form during the cell growth response. This model predicts that any mutation that deregulates the normal control of p53 conformation may lead to cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682937     DOI: 10.1098/rspb.1991.0100

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  19 in total

Review 1.  Molecular biology of testicular germ cell tumors: current status.

Authors:  B Schmidt; R Ackermann; T Strohmeyer
Journal:  J Mol Med (Berl)       Date:  1995-07       Impact factor: 4.599

2.  Increased salt concentration reversibly destabilizes p53 quaternary structure and sequence-specific DNA binding.

Authors:  S Butcher; P Hainaut; J Milner
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

3.  Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity.

Authors:  M Bocchetta; I Di Resta; A Powers; R Fresco; A Tosolini; J R Testa; H I Pass; P Rizzo; M Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.

Authors:  M V Blagosklonny; J Toretsky; S Bohen; L Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Modification of p53 protein profile by gamma irradiation followed by methyl donor starvation.

Authors:  Vipen Batra; Vellappan Kesavan; Kaushala P Mishra
Journal:  Mol Cell Biochem       Date:  2006-06-09       Impact factor: 3.396

6.  Translational regulation of human p53 gene expression.

Authors:  L Fu; M D Minden; S Benchimol
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

7.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

Authors:  M Hsiao; J Low; E Dorn; D Ku; P Pattengale; J Yeargin; M Haas
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 8.  Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings.

Authors:  V Gorgoulis; G Rassidakis; A Karameris; A Giatromanolaki; C Barbatis; C Kittas
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.

Authors:  C A Pise-Masison; M Radonovich; K Sakaguchi; E Appella; J N Brady
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras.

Authors:  J W Peacock; S Chung; R G Bristow; R P Hill; S Benchimol
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.